In vivo electrophysiology of nigral and thalamic neurons in alpha-synuclein-overexpressing mice highlights differences from toxin-based models of parkinsonism

Journal of Neurophysiology

Volumn 110, Issue 12, 2013, Pages 2792-2805

  Lobb, C J ^a   Zaheer, A K ^a   Smith, Y ^a,b   Jaeger, D ^a  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Basal ganglia; Mouse; Parkinson's disease; Recording; Thalamus

Indexed keywords

ALPHA SYNUCLEIN; DOPAMINE; TOXIN; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CONTROLLED STUDY; DENSITOMETRY; DOPAMINE DEFICIENT MOUSE; ELECTRIC POTENTIAL; ELECTROPHYSIOLOGY; GENE OVEREXPRESSION; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; MOTOR DYSFUNCTION; MOUSE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; OSCILLATION; PARKINSONISM; PRIMARY MOTOR CORTEX; PRIORITY JOURNAL; SUBSTANTIA NIGRA PARS RETICULATA; THALAMUS; THALAMUS VENTRAL NUCLEUS;

BASAL GANGLIA; MOUSE; PARKINSON'S DISEASE; RECORDING; THALAMUS;

ACTION POTENTIALS; ALPHA-SYNUCLEIN; ANIMALS; BETA RHYTHM; HUMANS; MALE; MICE; MOTOR CORTEX; NEURONS; OXIDOPAMINE; PARKINSON DISEASE; PARKINSON DISEASE, SECONDARY; SUBSTANTIA NIGRA; THALAMUS;

EID: 84890347851     PISSN: 00223077     EISSN: 15221598     Source Type: Journal    
DOI: 10.1152/jn.00441.2013     Document Type: Article

References (76)

1. Amzica F, Steriade M. Short-and long-range neuronal synchronization of the slow (1 Hz) cortical oscillation. J Neurophysiol 73: 20-38, 1995.
2. Aosaki T, Graybiel AM, Kimura M. Effect of the nigrostriatal dopamine system on acquired neural responses in the striatum of behaving monkeys. Science 265: 412-415, 1994.
3. Avila I, Parr-Brownlie LC, Brazhnik E, Castaneda E, Bergstrom DA, Walters JR. Beta frequency synchronization in basal ganglia output during rest and walk in a hemiparkinsonian rat. Exp Neurol 221: 307-319, 2010.
4. Azeredo da Silveira S, Schneider BL, Cifuentes-Diaz C, Sage D, Abbas-Terki T, Iwatsubo T, Unser M, Aebischer P. Phosphorylation does not prompt, nor prevent, the formation of alpha-synuclein toxic species in a rat model of Parkinson's disease. Hum Mol Genet 18: 872-887, 2009.
5. Belluscio MA, Kasanetz F, Riquelme LA, Murer MG. Spreading of slow cortical rhythms to the basal ganglia output nuclei in rats with nigrostriatal lesions. Eur J Neurosci 17: 1046-1052, 2003.
6. Berens P. CircStat: a MATLAB toolbox for circular statistics. J Stat Software 31: 1-21, 2009.
7. Brazhnik E, Cruz AV, Avila I, Wahba MI, Novikov N, Ilieva NM, McCoy AJ, Gerber C, Walters JR. State-dependent spike and local field synchronization between motor cortex and substantia nigra in hemiparkinsonian rats. J Neurosci 32: 7869-7880, 2012.
8. Brown P, Oliviero A, Mazzone P, Insola A, Tonali P, Di Lazzaro V. Dopamine dependency of oscillations between subthalamic nucleus and pallidum in Parkinson's disease. J Neurosci 21: 1033-1038, 2001.
9. Chartier-Harlin MC, Kachergus J, Roumier C, Mouroux V, Douay X, Lincoln S, Levecque C, Larvor L, Andrieux J, Hulihan M, Waucquier N, Defebvre L, Amouyel P, Farrer M, Destee A. Alpha-synuclein locus duplication as a cause of familial Parkinson's disease. Lancet 364: 1167-1169, 2004.
10. Chesselet MF, Richter F, Zhu C, Magen I, Watson MB, Subramaniam SR. A progressive mouse model of Parkinson's disease: the Thy1-aSyn ("Line 61") mice. Neurotherapeutics 9: 297-314, 2012.
11. Contreras D, Steriade M. Cellular basis of EEG slow rhythms: a study of dynamic corticothalamic relationships. J Neurosci 15: 604-622, 1995.
12. Degos B, Deniau JM, Chavez M, Maurice N. Chronic but not acute dopaminergic transmission interruption promotes a progressive increase in cortical beta frequency synchronization: relationships to vigilance state and akinesia. Cereb Cortex 19: 1616-1630, 2009.
13. Ding JB, Guzman JN, Peterson JD, Goldberg JA, Surmeier DJ. Thalamic gating of corticostriatal signaling by cholinergic interneurons. Neuron 67: 294-307, 2010.
14. Eusebio A, Brown P. Oscillatory activity in the basal ganglia. Parkinsonism Relat Disord 13, Suppl 3: S434-S436, 2007.
15. Farrer M, Kachergus J, Forno L, Lincoln S, Wang DS, Hulihan M, Maraganore D, Gwinn-Hardy K, Wszolek Z, Dickson D, Langston JW. Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications. Ann Neurol 55: 174-179, 2004.
16. Fisher NI. Statistical Analysis of Circular Data. New York: Cambridge Univ. Press, 1995.
17. Fleming SM, Salcedo J, Fernagut PO, Rockenstein E, Masliah E, Levine MS, Chesselet MF. Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synuclein. J Neurosci 24: 9434-9440, 2004.
18. Fleming SM, Salcedo J, Hutson CB, Rockenstein E, Masliah E, Levine MS, Chesselet MF. Behavioral effects of dopaminergic agonists in transgenic mice overexpressing human wildtype alpha-synuclein. Neuroscience 142: 1245-1253, 2006.
19. Franklin KB, Paxinos G. The Mouse Brain in Stereotaxic Coordinates. San Diego, CA: Academic, 2008.
20. Galvan A, Hu X, Smith Y, Wichmann T. Localization and pharmacological modulation of GABA-B receptors in the globus pallidus of parkinsonian monkeys. Exp Neurol 229: 429-439, 2011.
21. Gatev P, Darbin O, Wichmann T. Oscillations in the basal ganglia under normal conditions and in movement disorders. Mov Disord 21: 1566-1577, 2006.
22. Gaugler MN, Genc O, Bobela W, Mohanna S, Ardah MT, El-Agnaf OM, Cantoni M, Bensadoun JC, Schneggenburger R, Knott GW, Aebischer P, Schneider BL. Nigrostriatal overabundance of alpha-synuclein leads to decreased vesicle density and deficits in dopamine release that correlate with reduced motor activity. Acta Neuropathol (Berl) 123: 653-669, 2012.
23. Gwinn-Hardy K, Mehta ND, Farrer M, Maraganore D, Muenter M, Yen SH, Hardy J, Dickson DW. Distinctive neuropathology revealed by alphasynuclein antibodies in hereditary parkinsonism and dementia linked to chromosome 4p. Acta Neuropathol (Berl) 99: 663-672, 2000.
24. Hadipour Niktarash A. Transmission of the subthalamic nucleus oscillatory activity to the cortex: a computational approach. J Comput Neurosci 15: 223-232, 2003.
25. Holt G, Softky WR, Koch C, Douglas RJ. Comparison of discharge variability in vitro and in vivo in cat visual cortex neurons. J Neurophysiol 75: 1806-1814, 1996.
26. Hwang DY, Fleming SM, Ardayfio P, Moran-Gates T, Kim H, Tarazi FI, Chesselet MF, Kim KS. 3,4-Dihydroxyphenylalanine reverses the motor deficits in Pitx3-deficient aphakia mice: behavioral characterization of a novel genetic model of Parkinson's disease. J Neurosci 25: 2132-2137, 2005.
27. Ikeuchi T, Kakita A, Shiga A, Kasuga K, Kaneko H, Tan CF, Idezuka J, Wakabayashi K, Onodera O, Iwatsubo T, Nishizawa M, Takahashi H, Ishikawa A. Patients homozygous and heterozygous for SNCA duplication in a family with parkinsonism and dementia. Arch Neurol 65: 514-519, 2008.
28. Klein C, Westenberger A. Genetics of Parkinson's disease. Cold Spring Harb Perspect Med 2: a008888, 2012.
29. Ko D, Wilson CJ, Lobb CJ, Paladini CA. Detection of bursts and pauses in spike trains. J Neurosci Methods 211: 145-158, 2012.
30. Kruger R, Kuhn W, Muller T, Woitalla D, Graeber M, Kosel S, Przuntek H, Epplen JT, Schols L, Riess O. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet 18: 106-108, 1998.
31. Kuramoto E, Fujiyama F, Nakamura KC, Tanaka Y, Hioki H, Kaneko T. Complementary distribution of glutamatergic cerebellar and GABAergic basal ganglia afferents to the rat motor thalamic nuclei. Eur J Neurosci 33: 95-109, 2011.
32. Lam HA, Wu N, Cely I, Kelly RL, Hean S, Richter F, Magen I, Cepeda C, Ackerson LC, Walwyn W, Masliah E, Chesselet MF, Levine MS, Maidment NT. Elevated tonic extracellular dopamine concentration and altered dopamine modulation of synaptic activity precede dopamine loss in the striatum of mice overexpressing human alpha-synuclein. J Neurosci Res 89: 1091-1102, 2011.
33. Lang AE, Obeso JA. Time to move beyond nigrostriatal dopamine deficiency in Parkinson's disease. Ann Neurol 55: 761-765, 2004.
34. Leblois A, Meissner W, Bioulac B, Gross CE, Hansel D, Boraud T. Late emergence of synchronized oscillatory activity in the pallidum during progressive Parkinsonism. Eur J Neurosci 26: 1701-1713, 2007.
35. Levy R, Ashby P, Hutchison WD, Lang AE, Lozano AM, Dostrovsky JO. Dependence of subthalamic nucleus oscillations on movement and dopamine in Parkinson's disease. Brain 125: 1196-1209, 2002.
36. Llinas R, Greenfield SA, Jahnsen H. Electrophysiology of pars compacta cells in the in vitro substantia nigra-a possible mechanism for dendritic release. Brain Res 294: 127-132, 1984.
37. Lu SM, Guido W, Sherman SM. Effects of membrane voltage on receptive field properties of lateral geniculate neurons in the cat: contributions of the low-threshold Ca2 conductance. J Neurophysiol 68: 2185-2198, 1992.
38. MacLeod NK, Ryman A, Arbuthnott GW. Electrophysiological properties of nigrothalamic neurons after 6-hydroxydopamine lesions in the rat. Neuroscience 38: 447-456, 1990.
39. Magill PJ, Bolam JP, Bevan MD. Dopamine regulates the impact of the cerebral cortex on the subthalamic nucleus-globus pallidus network. Neuroscience 106: 313-330, 2001.
40. Mallet N, Micklem BR, Henny P, Brown MT, Williams C, Bolam JP, Nakamura KC, Magill PJ. Dichotomous organization of the external globus pallidus. Neuron 74: 1075-1086, 2012.
41. Mallet N, Pogosyan A, Marton LF, Bolam JP, Brown P, Magill PJ. Parkinsonian beta oscillations in the external globus pallidus and their relationship with subthalamic nucleus activity. J Neurosci 28: 14245-14258, 2008a.
42. Mallet N, Pogosyan A, Sharott A, Csicsvari J, Bolam JP, Brown P, Magill PJ. Disrupted dopamine transmission and the emergence of exaggerated beta oscillations in subthalamic nucleus and cerebral cortex. J Neurosci 28: 4795-4806, 2008b.
43. Mardia KV. A non-parametric test for the bivariate two-sample location problem. J R Stat Soc Ser B 29: 320-342, 1967.
44. Masliah E, Rockenstein E, Veinbergs I, Mallory M, Hashimoto M, Takeda A, Sagara Y, Sisk A, Mucke L. Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. Science 287: 1265-1269, 2000.
45. Matsuura K, Kabuto H, Makino H, Ogawa N. Pole test is a useful method for evaluating the mouse movement disorder caused by striatal dopamine depletion. J Neurosci Methods 73: 45-48, 1997.
46. McCarthy MM, Moore-Kochlacs C, Gu X, Boyden ES, Han X, Kopell N. Striatal origin of the pathologic beta oscillations in Parkinson's disease. Proc Natl Acad Sci USA 108: 11620-11625, 2011.
47. McGeorge AJ, Faull RL. The organization of the projection from the cerebral cortex to the striatum in the rat. Neuroscience 29: 503-537, 1989.
48. Moore BR. A modification of the Rayleigh test for vector data. Biometrika 67: 175-180, 1980.
49. Murer MG, Riquelme LA, Tseng KY, Pazo JH. Substantia nigra pars reticulata single unit activity in normal and 6-OHDA-lesioned rats: effects of intrastriatal apomorphine and subthalamic lesions. Synapse 27: 278-293, 1997.
50. Nakamura KC, Sharott A, Magill PJ. Temporal coupling with cortex distinguishes spontaneous neuronal activities in identified basal gangliarecipient and cerebellar-recipient zones of the motor thalamus. Cereb Cortex (October 4, 2012). doi:10.1093/cercor/bhs287.
51. Nalls MA, Plagnol V, Hernandez DG, Sharma M, Sheerin UM, Saad M, Simon-Sanchez J, Schulte C, Lesage S, Sveinbjornsdottir S, Stefansson K, Martinez M, Hardy J, Heutink P, Brice A, Gasser T, Singleton AB, Wood NW. Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies. Lancet 377: 641-649, 2011.
52. Obi T, Nishioka K, Ross OA, Terada T, Yamazaki K, Sugiura A, Takanashi M, Mizoguchi K, Mori H, Mizuno Y, Hattori N. Clinicopathologic study of a SNCA gene duplication patient with Parkinson disease and dementia. Neurology 70: 238-241, 2008.
53. Ogawa N, Hirose Y, Ohara S, Ono T, Watanabe Y. A simple quantitative bradykinesia test in MPTP-treated mice. Res Commun Chem Pathol Pharmacol 50: 435-441, 1985.
54. Papachroni K, Ninkina N, Wanless J, Kalofoutis AT, Gnuchev NV, Buchman VL. Peripheral sensory neurons survive in the absence of alpha-and gamma-synucleins. J Mol Neurosci 25: 157-164, 2005.
55. Pare D, Curro'Dossi R, Steriade M. Neuronal basis of the parkinsonian resting tremor: a hypothesis and its implications for treatment. Neuroscience 35: 217-226, 1990.
56. Parr-Brownlie LC, Poloskey SL, Bergstrom DA, Walters JR. Parafascicular thalamic nucleus activity in a rat model of Parkinson's disease. Exp Neurol 217: 269-281, 2009.
57. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Di Iorio G, Golbe LI, Nussbaum RL. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276: 2045-2047, 1997.
58. Quiroga-Varela A, Walters JR, Brazhnik E, Marin C, Obeso JA. What basal ganglia changes underlie the parkinsonian state? The significance of neuronal oscillatory activity. Neurobiol Dis 58C: 242-248, 2013.
59. Rockenstein E, Mallory M, Hashimoto M, Song D, Shults CW, Lang I, Masliah E. Differential neuropathological alterations in transgenic mice expressing alpha-synuclein from the platelet-derived growth factor and Thy-1 promoters. J Neurosci Res 68: 568-578, 2002.
60. Sanderson P, Mavoungou R, Albe-Fessard D. Changes in substantia nigra pars reticulata activity following lesions of the substantia nigra pars compacta. Neurosci Lett 67: 25-30, 1986.
61. Sedelis M, Schwarting RK, Huston JP. Behavioral phenotyping of the MPTP mouse model of Parkinson's disease. Behav Brain Res 125: 109-125, 2001.
62. Sharott A, Magill PJ, Harnack D, Kupsch A, Meissner W, Brown P. Dopamine depletion increases the power and coherence of beta-oscillations in the cerebral cortex and subthalamic nucleus of the awake rat. Eur J Neurosci 21: 1413-1422, 2005.
63. Siapas AG, Lubenov EV, Wilson MA. Prefrontal phase locking to hippocampal theta oscillations. Neuron 46: 141-151, 2005.
64. Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J, Hulihan M, Peuralinna T, Dutra A, Nussbaum R, Lincoln S, Crawley A, Hanson M, Maraganore D, Adler C, Cookson MR, Muenter M, Baptista M, Miller D, Blancato J, Hardy J, Gwinn-Hardy K. Alpha-synuclein locus triplication causes Parkinson's disease. Science 302: 841, 2003.
65. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M. Alpha-synuclein in Lewy bodies. Nature 388: 839-840, 1997.
66. Steriade M, Amzica F, Nunez A. Cholinergic and noradrenergic modulation of the slow (approximately 0.3 Hz) oscillation in neocortical cells. J Neurophysiol 70: 1385-1400, 1993a.
67. Steriade M, Nunez A, Amzica F. A novel slow (1 Hz) oscillation of neocortical neurons in vivo: depolarizing and hyperpolarizing components. J Neurosci 13: 3252-3265, 1993b.
68. Sulzer D. Clues to how alpha-synuclein damages neurons in Parkinson's disease. Mov Disord 25, Suppl 1: S27-S31, 2010.
69. Tillerson JL, Caudle WM, Reveron ME, Miller GW. Detection of behavioral impairments correlated to neurochemical deficits in mice treated with moderate doses of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Exp Neurol 178: 80-90, 2002.
70. Volgushev M, Chauvette S, Mukovski M, Timofeev I. Precise long-range synchronization of activity and silence in neocortical neurons during slow-wave oscillations. J Neurosci 26: 5665-5672, 2006.
71. Walters JR, Hu D, Itoga CA, Parr-Brownlie LC, Bergstrom DA. Phase relationships support a role for coordinated activity in the indirect pathway in organizing slow oscillations in basal ganglia output after loss of dopamine. Neuroscience 144: 762-776, 2007.
72. Wichmann T, Dostrovsky JO. Pathological basal ganglia activity in movement disorders. Neuroscience 198: 232-244, 2011.
73. Wu N, Joshi PR, Cepeda C, Masliah E, Levine MS. Alpha-synuclein overexpression in mice alters synaptic communication in the corticostriatal pathway. J Neurosci Res 88: 1764-1776, 2010.
74. Zar JH. Biostatistical Analysis. Upper Saddle River, NJ: Prentice Hall, 1999.
75. Zarranz JJ, Alegre J, Gomez-Esteban JC, Lezcano E, Ros R, Ampuero I, Vidal L, Hoenicka J, Rodriguez O, Atares B, Llorens V, Gomez Tortosa E, del Ser T, Munoz DG, de Yebenes JG. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 55: 164-173, 2004.
76. Zold CL, Ballion B, Riquelme LA, Gonon F, Murer MG. Nigrostriatal lesion induces D2-modulated phase-locked activity in the basal ganglia of rats. Eur J Neurosci 25: 2131-2144, 2007.